Photo of Copper3D

Meet an Unreasonable Company

Copper3D

Setting a new standard in the 3D printing industry by developing antibacterial nanocomposites that fight bacteria for printed prosthetics.

Photo of Daniel Martínez

Daniel Martínez

Co-Founder & Director of Innovation at Copper3D

Learn more about Daniel »
Employees 6–20
Headquarters Santiago, Santiago Metropolitan Region, Chile

10% of all patients admitted in a hospital will get a Hospital-Acquired Infection. Copper3D is revolutionizing the 3D printing industry with a patented and highly effective additive based on copper nanoparticles to "hack" materials and transform them into fully antimicrobial. Copper3D's first product is now available: a high quality PLA polymer called PLACTIVE, which eliminates a wide range of microorganisms. They also developed a medical-grade material called NANOCLEAN, a PETG polymer with additive concentration of 1% aimed at more specific purposes in medical devices. Copper3D's printing materials, as well as objects 3D printed with Copper3D's materials, have been tested and validated by the Microbiology Laboratory of the Universidad Católica de Valparaíso, Chile, and the laboratory SITU Biosciences in the U.S.
PLACTIVE was also clinically tested in 3D printed prosthetics for U.S. war veterans and currently is tested by NASA for 3D printed applications in long term space missions.
This new breed of "Active Materials" will transform several industries from Healthcare, Medical Devices, Food, Animal Care, Aerospace, among others.

Recent Press

February 23, 2020

Copper3D Antimicrobial Filament Device Attempts To Reduce HIV Transmission From Breastfeeding

April 14, 2020

Copper masks made by Chile company in COVID-19 fight

February 4, 2019

NASA awards Copper 3D grant for 3D printing antibacterial medical devices in space - 3D Printing Industry

More Companies in Health

Get the Unreasonable Newsletter

Get twice-monthly updates on Copper3D and over 300 other companies working to solve the world’s toughest problems.

Read our Privacy Policy.